US Generic Injectables Market Price Trends, Size, Share, Analysis and Forecast 2022-2027

 According to the latest report by IMARC Group, titled "US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the US generic injectables market reached a value of US$ 16.3 Billion in 2021. Injectables refer to medication delivery tools that are generally used by healthcare professionals for drug administration into the body. They are widely used as a preferred alternative to oral drugs since injectables are quick in delivering drugs selectively to a specific body part while improving the efficacy of the dosage. Generic injectables are bioequivalent of branded injectables that are manufactured after the expiration of the patent of proprietary injectables. The demand for generic injectables is rising in the US since they are identical in terms of dosage, same active ingredients, side effects, route of administration, strength and quality.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Report Sample: https://www.imarcgroup.com/us-generic-injectables-market/requestsample

The market in the US is primarily driven by the augmenting demand for affordable injectables among the masses. This is supported by the rising prevalence of lifestyle disorders due to the sedentary lifestyles led by individuals. Moreover, the increasing funding activities by major players in extensive research and development (R&D) activities for the development of differentiated generic injectables are further creating a positive market outlook. Along with this, several initiatives undertaken by the US government for providing support to key manufacturers and sellers are positively influencing the market. Additionally, the widespread adoption of advanced technologies in the manufacturing process is acting as a major growth-inducing factor across the country. Other factors, including the easy availability of generic injectables via online and offline pharmacies, patent expiration of several blockbuster injectables and the widespread awareness regarding the cost-efficiency of these injectables, are also favorably impacting the market growth. On account of the aforementioned factors,the market is anticipated to reach a value of US$ 29.6 Billion, growing at a CAGR of 10.21% during 2022-2027.

Competitive Landscape With Key Players:

The competitive landscape of the US generic injectables market has been studied in the report with the detailed profiles of the key players operating in the market.

Key Market Segmentation:

The report has segmented the US generic injectables market on the basis of therapeutic area, containers, distribution channel, end user and region.

Breakup by Therapeutic Area:

• Oncology
• Anesthesia
• Anti-infectives
• Parenteral Nutrition
• Cardiovascular

Breakup by Containers:

• Vials
• Ampoules
• Premix
• Prefilled Syringes

Breakup by Distribution Channel:

• Hospitals
• Retail Pharmacy

Explore Full Report with TOC & List of Figure: https://bit.ly/39Rid0t

Key highlights of the report:            

• Market Performance (2015-2020)
• Market Outlook (2021-2026)
• Industry Trends
• Market Drivers and Success Factors
• The Impact of COVID-19 on the Global Market
• Value Chain Analysis
• Structure of the Global Market
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us                                                                      

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800